{"schema_version":"secwatch.filing_event.v1","accession":"0001764046-26-000085","form_type":"8-K","ticker":"CLVT","cik":"0001764046","company_name":"CLARIVATE PLC","filed_at":"2026-07-06T10:01:11+00:00","discovered_at":"2026-07-06T10:05:00.295899+00:00","generated_at":"2026-07-06T10:05:23.506051+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Clarivate sells Life Sciences & Healthcare segment to Altaris for $600M","bullets":["Deal value $600M: $500M cash at close, $25M deferred cash, $75M seller note.","Proceeds to reduce debt; transaction expected to close by end of 2026.","Reaffirms FY2026 outlook; LS&H to be classified as discontinued ops from Q3.","Expects non-cash goodwill impairment of $225-250M on LS&H segment.","Company sharpens focus on Academia & Government and Intellectual Property segments."],"urls":{"canonical":"https://secwatch.observer/filing/0001764046-26-000085","json":"https://secwatch.observer/filing/0001764046-26-000085.json","markdown":"https://secwatch.observer/filing/0001764046-26-000085.md","text":"https://secwatch.observer/filing/0001764046-26-000085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764046/000176404626000085/0001764046-26-000085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764046/000176404626000085/clvt-20260706.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-06T10:05:23.506051+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}